Abstract
Studies with IL-23-deficient mice revealed the critical role of IL-23 and in particular IL-17-producing cells, including TH17 cells, in the initiation of experimental auto-immune arthritis. Interestingly, the recognition of TH17 cells and TH17 cytokines at the very early stage of rheumatoid arthritis (RA) fits with the concept that the IL-23/TH17 immune pathway is important in the development of this auto-immune disease. However, the exact biological role of this immune pathway in the development of RA and other arthropathies needs further examination. The first data from clinical trials using anti-IL-17A antibody treatment in psoriatic arthritis and RA is promising. Whether the regulation of TH17 cell activity or specific combinations of TH17 cytokines will have additional value compared to neutralizing IL-17A activity or TNF needs to be elucidated. However, first evidence from in vitro studies showed that the inhibition of the TH17 pathway in addition to anti-TNF suppressed the pro-inflammatory feedback loop between TH17 cells and synovial fibroblasts of patients with early RA. This approach may help to reach the ultimate goal of permanent remission or even prevent the development of this crippling disease. In addition, further understanding of the plasticity of T cell subsets in the pathogenesis of chronic destructive arthritis especially at different stages of the disease will be essential to understanding the T cell biology in RA. Moreover, understanding T cell plasticity due to different therapies may further improve treatment of patients with chronic destructive arthritis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aarvak T, Chabaud M, Kallberg E (1999) Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium. Scand J Immunol 50:1–9.
Abdulahad WH, Stegeman CA, Limburg PC et al (2008) Skewed distribution of Th17 lymphocytes in patients with Wegener’s granulomatosis in remission. Arthritis Rheum 58:2196–2205.
Arend WP, Dayer J-M (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38:151–60.
Bombara MP, Webb DL, Conrad P et al (1993) Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J Leuk Biol 54:399–406.
Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537–3545.
Bush KA, Farmer KM, Walker JS et al (2002) Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum 46:802–805.
Bush KA, Walker JS, Lee CS et al (2001) Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol 123:487–495.
Chabaud M, Durand JM, Buchs N et al (1999) Human interleukin-17: a T cell-derived pro-inflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–70.
Chabaud M, Miossec P (2001) The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum 44:1293–03.
Ciccia F, Bombardieri M, Principato A et al (2009) Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 60:955–965.
Codolo G, Amedei A, Steere AC et al (2008) Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum 58:3609–3617.
Colin EM, Asmawidjaja PS, van Hamburg JP et al (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62:132–42.
Cornelissen F, Mus AM, Asmawidjaja PS et al (2009) Interleukin-23 is critical for full-blown expression of a non-auto-immune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells. Arthritis Res Ther 11:R194. Epub 2009 Dec 17.
Cornelissen F, Van Hamburg JP, Lubberts E (2009) The IL-12/IL-23 axis and its role in the Th17 cell development, pathology and plasticity in arthritis. Curr Opin Invest Drugs 10:452–462.
Corthay A, Johansson A, Vestberg M et al (1999) Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice. Int Immunol 11:1065–1073.
Daha NA, Kurreeman FA, Marques RB et al (2009) Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum 60:1255–1260.
de Kleer IM, Wedderburn LR, Taams LS et al (2004) CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435–6443.
Dolhain RJ, van der Heiden AN, ter Haar NT et al (1996) Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 39:1961–1969.
Doodes PD, Cao Y, Hamel KM et al (2008) Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol 181:329–337
Doodes PD, Cao Y, Hamel KM et al (2010) IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J Immunol 184:1552–1559.
Duhen T, Geiger R, Jarrossay D et al (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature Immunol 10:857–863.
Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361.
Fossiez F, Djossou O, Chomarat P et al (1996) T cell interleukin-17 induces stromal cells to produce pro-inflammatory and hematopoietic cytokines. J Exp Med 183:2593–03.
Fujimoto M, Serada S, Mihara M et al (2008) Interleukin-6 blockade suppresses auto-immune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum 58:3710–3719.
Geboes L, Dumoutier L, Kelchtermans H et al (2009) Pro-inflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 60:390–395.
Germann T, Szeliga J, Hess H et al (1995) Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. PNAS 92:4823–4827.
Herber D, Brown TP, Liang S et al (2007) IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 178:3822–3830.
Hess H, Gately MK, Rude E et al (1996) High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund’s adjuvant. Eur J Immunol 26:187–191.
Hirota K, Yoshitomi H, Hashimoto M et al (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204:2803–2812.
Holoshitz J, Koning F, Coligan JE et al (1989) Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 339:226–229.
Hsu HC, Yang P, Wang J et al (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in auto-immune BXD2 mice. Nature Immunol 9:166–175.
Hymowitz SG, Filvaroff EH, Yin JP et al (2001) IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20:5332–5341.
Ikeuchi H, Kuroiwa T, Hiramatsu N et al (2005) Expression of interleukin-22 in rheumatoid arthritis: potential role as a pro-inflammatory cytokine. Arthritis Rheum 52:1037–1046.
Ishigame H, Kakuta S, Nagai T et al (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30:108–119.
Ivanov, II, McKenzie BS, Zhou L et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of pro-inflammatory IL-17+ T helper cells. Cell 126:1121–1133.
Iwakura Y, Nakae S, Saijo S et al (2008) The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 226:57–79.
Jandus C, Bioley G, Rivals JP et al (2008) Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 58:2307–2317.
Jang E, Cho SH, Park H et al (2009) A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in auto-immune K/BxN mice. J Immunol 182:4649–4656.
Jensen KD, Su X, Shin S et al (2008) Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29:90–100.
Joosten LA, Lubberts E, Helsen MM et al (1997) Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 159:4094–4102.
Jovanovic DV, DiBattista JA, Martel-Pelletier J et al (1998) IL-17 stimulates the production and expression of pro-inflammatory cytokines, IL-1beta and TNFalpha, by human macrophages. J Immunol 160:3513–21.
Ju JH, Cho ML, Moon YM et al (2008) IL-23 induces receptor activator of NF-kappaB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an auto-immune arthritis model. J Immunol 181:1507–1518.
Kasama T, Yamazaki J, Hanaoka R et al (1999) Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha. Arthritis Rheum 42:100–109.
Kirkham BW, Lassere MN, Edmonds JP et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 54:1122–1131.
Kjeldsen-Kragh J, Quayle A, Kalvenes C et al (1990) T gamma delta cells in juvenile rheumatoid arthritis and rheumatoid arthritis. In the juvenile rheumatoid arthritis synovium the T gamma delta cells express activation antigens and are predominantly V delta 1+, and a significant proportion of these patients have elevated percentages of T gamma delta cells. Scand J Immunol 32:651–659.
Koenecke C, Chennupati V, Schmitz S et al (2009) In vivo application of mAb directed against the gammadelta TCR does not deplete but generates “invisible” gammadelta T cells. Eur J Immunol 39:372–379.
Koenen HJ, Smeets RL, Vink PM et al (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112:2340–2352.
Korn T, Bettelli E, Gao W et al (2007) IL-21 initiates an alternative pathway to induce pro-inflammatory T(H)17 cells. Nature 448:484–487.
Korn T, Bettelli E, Oukka M et al (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517.
Kotake S, Udagawa N, Takahashi N et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352.
Kotloski NJ, Nardelli DT, Peterson SH et al (2008) Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol 15:1199–1207.
Kreymborg K, Etzensperger R, Dumoutier L et al (2007) IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of auto-immune encephalomyelitis. J Immunol 179:8098–8104.
Kroenke MA, Carlson TJ, Andjelkovic AV et al (2008) IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 205:1535–1541.
Kurasawa K, Hirose K, Sano H (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455–2463
Lai Kwan Lam Q, King Hung Ko O, Zheng BJ et al (2008) Local BAFF gene silencing suppresses Th17-cell generation and ameliorates auto-immune arthritis. PNAS 105:14993–14998.
Lee YK, Turner H, Maynard CL et al (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30:92–107.
Lexberg MH, Taubner A, Forster A et al (2008) Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 38:2654–2664.
Liang SC, Tan XY, Luxenberg DP et al (2006) Interleukin (IL)-22 and IL-17 are co-expressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279.
Lochner M, Peduto L, Cherrier M et al (2008) In vivo equilibrium of pro-inflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med 205:1381–1393.
Lubberts E (2003) The role of IL-17 and family members in the pathogenesis of arthritis. Curr Opin Investig Drugs 4:572–7.
Lubberts E (2008) IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 41:84–91.
Lubberts E (2010) Th17 cytokines and arthritis. Semin Immunopathol 32:43–53
Lubberts E, Joosten LA, Oppers B et al (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167:1004–1013.
Lubberts E, Joosten LAB, Van de Loo FA et al (2002) Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflam Res 51:102–4.
Lubberts E, Koenders MI, Oppers-Walgreen B et al (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659.
Lubberts E, Koenders MI, van den Berg WB (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7:29–37.
Lubberts E, Schwarzenberger P, Huang W et al (2005) Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J Immunol 175:3360–8.
Luger D, Silver PB, Tang J et al (2008) Either a Th17 or a Th1 effector response can drive auto-immunity: conditions of disease induction affect dominant effector category. J Exp Med 205:799–810.
Malfait AM, Butler DM, Presky DH et al (1998) Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol 111:377–383.
Martin-Orozco N, Chung Y, Chang SH et al (2009) Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39:216–224.
Matthys P, Vermeire K, Mitera T et al (1998) Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol 28:2143–2151.
McGeachy MJ, Bak-Jensen KS, Chen Y et al (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8:1390–1397.
McInnes IB, Leung BP, Liew FY (2000) Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res 2:374–378.
McIntyre KW, Shuster DJ, Gillooly KM et al (1996) Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur J Immunol 26:2933–2938.
Meyers JA, Mangini AJ, Nagai T et al (2006) Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine 35:235–246.
Miossec P (2003) Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 48:594–601.
Moisan J, Grenningloh R, Bettelli E et al (2007) Ets-1 is a negative regulator of Th17 differentiation. J Exp Med 204:2825–2835.
Morita Y, Yamamura M, Kawashima M et al (1998) Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 41:1669–1676.
Murphy CA, Langrish CL, Chen Y et al (2003) Divergent pro and anti-inflammatory roles for IL-23 and IL-12 in joint auto-immune inflammation. J Exp Med 198:1951–1957.
Mus AMC, Cornelissen F, Asmawidjaja PS et al (2010) Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for interleukin-22, but not interleukin-21, in auto-immune experimental arthritis. Arthritis Rheum 62:1043–1050.
Nakae S, Saijo S, Horai R et al (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. PNAS 100:5986–5990.
Nakajima A, Seroogy CM, Sandora MR et al (2001) Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 107:1293–1301.
Nguyen CQ, Hu MH, Li Y et al (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren’s syndrome: findings in humans and mice. Arthritis Rheum 58:734–743.
Nistala K, Moncrieffe H, Newton KR et al (2008) Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 58:875–887.
Notley CA, Inglis JJ, Alzabin S et al (2008) Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immune-regulatory pathway for Th1 and Th17 cells. J Exp Med 205:2491–2497.
Nurieva R, Yang XO, Martinez G et al (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480–483.
Ogura H, Murakami M, Okuyama Y et al (2008) Interleukin-17 promotes auto-immunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29:628–636.
Oppmann B, Lesley R, Blom B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725.
Parks E, Strieter RM, Lukacs NW et al (1998) Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis. J Immunol 160:4615–4619.
Parsonage G, Filer A, Bik M et al (2008) Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthritis Res Ther 10:R47.
Pelegri C, Kuhnlein P, Buchner E et al (1996) Depletion of gamma/delta T cells does not prevent or ameliorate, but rather aggravates, rat adjuvant arthritis. Arthritis Rheum 39:204–215.
Peterman GM, Spencer C, Sperling AI et al (1993) Role of gamma delta T cells in murine collagen-induced arthritis. J Immunol 151:6546–6558.
Rachitskaya AV, Hansen AM, Horai R et al (2008) Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180:5167–5171.
Radhakrishnan S, Cabrera R, Schenk EL et al (2008) Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific auto-immune effectors in vitro and in vivo. J Immunol 181:3137–3147.
Radstake TR, van Bon L, Broen J et al (2009) The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PloS One 4:e5903.
Raza K, Falciani F, Curnow SJ et al (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7:R784-795.
Renauld JC (2003) Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nature Rev 3:667–676.
Roark CL, French JD, Taylor MA et al (2007) Exacerbation of Collagen-Induced Arthritis by Oligoclonal, IL-17-Producing {gamma}{delta} T Cells. J Immunol 179:5576–5583.
Roark CL, Simonian PL, Fontenot AP et al (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20:353–357.
Ruprecht CR, Gattorno M, Ferlito F et al (2005) Co-expression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201:1793–1803.
Sakai A, Sugawara Y, Kuroishi T et al (2008) Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181:2898–2906.
Sawalha AH, Kaufman KM, Kelly JA et al (2008) Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 67:458–461.
Shibata K, Yamada H, Hara H et al (2007) Resident V{delta}1+ {gamma}{delta} T Cells Control Early Infiltration of Neutrophils after Escherichia coli Infection via IL-17 Production. J Immunol 178:4466–4472.
Singh R, Aggarwal A, Misra R (2007) Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. J Rheum 34:2285–2290.
Stark MA, Huo Y, Burcin TL et al (2005) Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:285–294.
Sullivan KE, Piliero LM, Dharia T et al (2000) 3’ polymorphisms of ETS1 are associated with different clinical phenotypes in SLE. Human mutation 16:49–53.
Szeliga J, Hess H, Rude E et al (1996) IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis. Int Immunol 8:1221–1227.
Takahashi N, Vanlaere I, de Rycke R et al (2008) IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med 205:1755–1761.
Tran CN, Lundy SK, White PT et al (2007) Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells. Am J Pathol 171:1588–1598.
Trifari S, Kaplan CD, Tran EH et al (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nature Immunol 10:864–871.
Van Hamburg JP, Mus AM, de Bruijn MJ et al (2009) GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis. Arthritis Rheum 60:750–759.
Van Hamburg JP, Asmawidjaja PS, Davelaar N et al (2011) Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum 63:73–83.
Wang D, John SA, Clements JL et al (2005) Ets-1 deficiency leads to altered B cell differentiation, hyper-responsiveness to TLR9 and auto-immune disease. Internat Immunol 17:1179–1191.
Webb R, Merrill JT, Kelly JA et al (2009) A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum 60:2402–2407.
Wei G, Wei L, Zhu J et al (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30:155–167.
Wolk K, Witte E, Wallace E et al (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309–1323.
Wong CK, Ho CY, Li EK et al (2009) Elevation of pro-inflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589–593.
Xu L, Kitani A, Fuss I et al (2007) Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 178:6725–6729.
Yago T, Nanke Y, Kawamoto M et al (2007) IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther 9:R96.
Yamada H, Nakashima Y, Okazaki K et al (2008) Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 67:1299–1304.
Yang XO, Chang SH, Park H et al (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205:1063–1075.
Yang XO, Pappu BP, Nurieva R et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29–39.
Yao Z, Fanslow WC, Seldin MF et al (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811–21.
Yao Z, Painter SL, Fanslow WC et al (1995) Human IL-17: a novel cytokine derived from T cells. J Immunol 155:5483–86.
Zhou L, Ivanov, II, Spolski R et al (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunol 8:967–974.
Ziolkowska M, Koc A, Luszczykiewicz G et al (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164:2832–2838.
Zrioual S, Ecochard R, Tournadre A et al (2009) Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 182:3112–3120.
Acknowledgement
I would like to acknowledge all members of the Lubberts lab for their excellent input and discussions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lubberts, E. (2011). The Role of the IL-23/TH17 Immune Pathway in the Pathogenesis of Arthritis. In: Jiang, S. (eds) TH17 Cells in Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9371-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9371-7_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9370-0
Online ISBN: 978-1-4419-9371-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)